quinazolines has been researched along with az-628 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinkel, V; Gloor, SL; Grina, J; Hansen, JD; Hastings, G; Laird, ER; Mathieu, S; Moreno, D; Rana, S; Rasor, K; Ren, L; Rudolph, J; Sturgis, HL; Vigers, G; Voegtli, WC; Wenglowsky, S; Willis, B | 1 |
| Chu, P; Lou, M; Wang, Z; Yin, M | 1 |
| Li, H; Ma, C; Su, H; Xiong, J | 1 |
| Chen, L; Gong, Y; Hong, Z; Jiang, T; Mi, S; Qiu, J; Wang, Z; Ye, J; Zhang, W; Zheng, X; Zhu, Z | 1 |
4 other study(ies) available for quinazolines and az-628
| Article | Year |
|---|---|
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinase.
Topics: Animals; Antineoplastic Agents; Crystallography, X-Ray; Drug Design; Enzyme Activation; Humans; Inhibitory Concentration 50; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinazolines; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
STAT3 inhibitor sensitized KRAS-mutant lung cancers to RAF inhibitor by activating MEK/ERK signaling pathway.
Topics: Aminosalicylic Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins p21(ras); Quinazolines; raf Kinases; STAT3 Transcription Factor; Sulfonamides | 2019 |
The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Biomarkers, Tumor; Chemotherapy, Adjuvant; Computational Biology; Databases, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Isoquinolines; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Prognosis; Protein Kinase Inhibitors; Quinazolines; RNA-Seq; RNA, Messenger; Succinimides; Sulfonamides | 2021 |
AZ-628 delays osteoarthritis progression via inhibiting the TNF-α-induced chondrocyte necroptosis and regulating osteoclast formation.
Topics: Animals; Chondrocytes; Mice; Necroptosis; NF-kappa B; Osteoarthritis; Osteoclasts; Quinazolines; Tumor Necrosis Factor-alpha | 2022 |